Want to see HK:2158 full AI Analyst Report?
2158 Stock Chart & Stats
HK$5.58
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.58
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$3.25 - HK$7.22
Previous CloseN/A
Volume5.15M
Average Volume (3M)5.35M
Market Cap
HK$3.66B
Enterprise ValueHK$3.05K
Total Cash (Recent Filing)HK$2.22B
Total Debt (Recent Filing)HK$71.09M
Price to Earnings (P/E)44.7
Beta1.78
Next Earnings
Nov 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.16%
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,072,892,200
10 Day Avg. Volume2,207,208
30 Day Avg. Volume5,353,730
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)1.25
Price to Sales (P/S)5.73
P/FCF Ratio-87.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$6.80Price Target Upside21.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.05
Revenue Forecast (FY)HK$972.31M
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageVery low leverage reduces refinancing and solvency risk while preserving financial flexibility. A sizeable, stable equity base gives Yidu Tech capacity to continue investing in healthcare data and AI capabilities, absorb operating volatility, and fund growth without heavy reliance on debt.
2026 Earnings And Cash-flow InflectionThe shift from prior losses and cash burn to positive net income and cash generation is an important improvement in financial quality. If sustained, internally generated cash can support platform investment, reduce funding needs, and strengthen the company’s ability to scale its services.
Healthcare AI And Data Platform FocusYidu Tech operates in a structurally relevant area by helping life-sciences companies and healthcare providers manage medical data, generate evidence, and support clinical decisions. These use cases can deepen customer workflow integration and create recurring demand for specialized analytics platforms and services.
Bears Say
Core Operating LossesNegative operating profit and EBITDA indicate that reported earnings recovery has not yet translated into durable profitability from the core business. Until operating earnings improve consistently, Yidu Tech may have less capacity to reinvest, withstand execution setbacks, or demonstrate scalable economics.
Unstable Cash GenerationThe return to positive cash flow is encouraging, but the preceding multi-year burn and sharp year-to-year volatility weaken confidence in repeatability. Inconsistent cash conversion can constrain long-term planning and make investment capacity dependent on maintaining a still-unproven recovery.
Choppy Revenue And Low Capital EfficiencyA history of uneven revenue performance and weak shareholder returns suggests that growth has not consistently converted into efficient value creation. This raises questions about demand durability, pricing or cost discipline, and whether the business can generate attractive returns as it expands.
Yidu Tech, Inc. News
2158 FAQ
What was Yidu Tech, Inc.’s price range in the past 12 months?
Yidu Tech, Inc. lowest stock price was HK$3.25 and its highest was HK$7.22 in the past 12 months.
What is Yidu Tech, Inc.’s market cap?
Yidu Tech, Inc.’s market cap is HK$3.66B.
When is Yidu Tech, Inc.’s upcoming earnings report date?
Yidu Tech, Inc.’s upcoming earnings report date is Nov 20, 2026 which is in 50 days.
How were Yidu Tech, Inc.’s earnings last quarter?
Yidu Tech, Inc. released its earnings results on Jun 29, 2026. The company reported HK$0.094 earnings per share for the quarter.
Is Yidu Tech, Inc. overvalued?
According to Wall Street analysts Yidu Tech, Inc.’s price is currently Undervalued.
Does Yidu Tech, Inc. pay dividends?
Yidu Tech, Inc. pays a Notavailable dividend of HK$0.04 which represents an annual dividend yield of 1.16%. See more information on Yidu Tech, Inc. dividends here
What is Yidu Tech, Inc.’s EPS estimate?
Yidu Tech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yidu Tech, Inc. have?
Yidu Tech, Inc. has 1,072,892,200 shares outstanding.
What happened to Yidu Tech, Inc.’s price movement after its last earnings report?
Yidu Tech, Inc. reported an EPS of HK$0.094 in its last earnings report. Following the earnings report the stock price went up 6.421%.
Which hedge fund is a major shareholder of Yidu Tech, Inc.?
Currently, no hedge funds are holding shares in HK:2158
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yidu Tech, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$6.80 (21.86% Upside)
HK$6.80 (21.86% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.35%
12-Months-Change
Fundamentals
Return on Equity
1.16%
Trailing 12-Months
Asset Growth
-2.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Yidu Tech, Inc.
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
2158 Stock 12 Month Forecast
Average Price Target
HK$6.80
▲(21.86% Upside)
Technical Analysis
Ping An Healthcare and Technology Company
―
Kindstar Globalgene Technology, Inc.
―
Medlive Technology Co., Ltd.
―
NEUSOFT XIKANG HOLDINGS INC.
―
Xunfei Healthcare Technology Co., Ltd.
―